1-866-647-3279

13

Mar 2020

Fight Back Against Coronavirus – How to Get Your Human-Use Antiseptic Drugs To Market
Fight Back Against Coronavirus – How to Get Your Human-Use Antiseptic Drugs To Market
By
With the recent announcement that Coronovirus has gone pandemic, consumers are flooding supermarkets, and preparing for indeterminate periods of self-isolation. All the while the marketplace is reeling, seeing demand for […] Read More >>

13

Mar 2020

Information on How to Obtain and Use an Expected Claim Related to Emerging Viral Pathogens Including COVID-19 (Coronavirus)
Information on How to Obtain and Use an Expected Claim Related to Emerging Viral Pathogens Including COVID-19 (Coronavirus)
By
Companies following the media coverage surrounding Coronavirus may be interested to know that their Broad Spectrum viricides could be eligible to be used as an Expected Claim related to Emerging […] Read More >>

13

Mar 2020

Recommendations for Infection Prevention from Regulatory Bodies
Recommendations for Infection Prevention from Regulatory Bodies
By
Based on what is currently known about the novel coronavirus (COVID-19) and similar coronaviruses that cause SARS (Sudden Acute Respiratory Syndrome) and MERS (Middle East Respiratory Syndrome), the most common […] Read More >>

    Menu
    Online Learning
    Subscribe

    Stay up to date on regulatory and compliance updates, news, and events!

      © dicentra. All Rights Reserved.
      Privacy Statement | Terms & Conditions

      *Please note: dicentra and all its subsidiaries only provide cannabis consulting services for business conducted in Canada, to the exclusion of all other countries.